APA (7th ed.) Citation

SS, A., M, S., MS, Z., & J, K. (2025). Genetically engineered K562 cells augment NK cell cytotoxicity against acute myeloid leukemia and reduce dependency on IL-15. Medical oncology (Northwood, London, England), 42(6), 211. https://doi.org/10.1007/s12032-025-02769-3

Chicago Style (17th ed.) Citation

SS, Akhkand, Soleimani M, Zomorrod MS, and Kiani J. "Genetically Engineered K562 Cells Augment NK Cell Cytotoxicity Against Acute Myeloid Leukemia and Reduce Dependency on IL-15." Medical Oncology (Northwood, London, England) 42, no. 6 (2025): 211. https://doi.org/10.1007/s12032-025-02769-3.

MLA (9th ed.) Citation

SS, Akhkand, et al. "Genetically Engineered K562 Cells Augment NK Cell Cytotoxicity Against Acute Myeloid Leukemia and Reduce Dependency on IL-15." Medical Oncology (Northwood, London, England), vol. 42, no. 6, 2025, p. 211, https://doi.org/10.1007/s12032-025-02769-3.